Skip to Main Content

913

Views

0

CrossRef citations to date

0

Altmetric

Feature Articles

Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW

Sabyasachi Ghosh1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information

,

Ian Smith2 OptumInsight, Eden Prairie, MinnesotaView further author information

,

James Davidson2 OptumInsight, Eden Prairie, MinnesotaView further author information

,

Tao Fan1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsCorrespondence[email protected]
View further author information

,

Ninfa Candela1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information

,

Cynthia Tsang1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information

,

Troy Koch1 Takeda Pharmaceuticals U.S.A., Inc., Lexington, MassachusettsView further author information

&

Jason Fehr2 OptumInsight, Eden Prairie, MinnesotaCorrespondence[email protected]
View further author information